The Turkish Pharmaceuticals and Medical Devices Authority recently published the Guideline on the Inspection of Good Distribution Practices, the Guideline on Triggers of Routine and/or "for a Specific Reason" Inspections, the Guideline on Triggers of Inspections on Bioavailability/Bioequivalence Studies and the inspection results of the final quarter of 2021 on cosmetics and type 1 and type 19 biocidal products.